Key Insights

Highlights

Treatment Research

2 treatments under study, led by Esp Block

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04303585Unknown

SAP Versus ESP Block in Multimodal Pain Management in Mini-invasive Thoracic Surgery: an Observational Prospective Multicentric Study

Showing all 1 trials

Research Network

Common Treatments

  • Esp Block1
  • Sap Block1

Active Sponsors

  • A.O.U. Città della Salute e della Scienza - Molinette Hospital1
  • University of Trieste1
  • Cliniche Humanitas Gavazzeni1

Top Investigators

Related Conditions

  • Multimodal Pain Management1
  • Pain Postoperative1
  • Sap Block Versus Esp Block1

Activity Timeline